Skip to main content
. 2012 Jun 1;14(8):1018–1025. doi: 10.1093/neuonc/nos123

Table 2.

Descriptive characteristics of the medulloblastoma survivors and sibling participants

Characteristic Medulloblastoma Survivors (n = 109) Siblings (n = 143) P valuea
Gender
 Male 56 (51.4%) 65 (45.5%) NS
 Female 53 (48.6%) 78 (54.5%)
Age at time of questionnaire completion (yrs)
 Mean (SD) 30.9 (6.06) 34.3 (9.00) .0004
 Range 18.6–43.7 18.9–54.6
Ethnicity
 Caucasian 98 (89.9%) 131 (91.6%) NS
 Other 11 (10.1%) 5 (3.5%)
 Missing 0 (0%) 7 (4.9%)
Highest education level
 Less than 12th grade 7 (6.4%) 5 (3.5%) .0002
 High school graduate 32 (29.4%) 15 (10.5%)
 Further education 68 (62.4%) 123 (86.0%)
 Unknown 2 (1.8%) 0 (0%)
Age at diagnosis (yrs)
 Mean (SD) 8.0 (0.41) N/A
 Range 0.6–18.3
Time since diagnosis at time of questionnaire completion (yrs)
 Mean (SD) 22.8 (4.22) N/A
 Range 16.5–32.5
Received Chemotherapy
 Yes 53 (48.6%) N/A
 No 51 (46.8%)
 Unknown 5 (4.6%)
Radiation Doses (Gy) Mean (SD)
 Posterior Fossa (Segment 1) 50.4 (6.01) N/A
 Temporal (Segment 2) 43.1 (9.53)
 Frontal (Segment 3) 36.9 (7.64)
 Parietal/Occipital (Segment 4) 40.1 (8.21)
SOD2 (47T > C)
 TT 21 (19.3%) 34 (23.8%) NS
 CT 50 (45.9%) 78 (54.5%)
 CC 37 (33.9%) 31 (21.7%)
 Missing 1 (0.9%) 0
GPX1 (599C > T)
 CC 50 (45.9%) 71 (49.7%) NS
 CT 47 (43.1%) 58 (40.5%)
 TT 8 (7.3%) 8 (5.6%)
 Missing 4 (3.7%) 6 (4.2%)
GSTP1(1404A > G and 2294C > T)
 AA 45 (41.3%) 60 (42.0%) NS
 Non AA 64 (58.7%) 83 (58%)
GSTM1 (Gene deletion)
 Null 51 (46.8%) 71 (49.6%) NS
 Non-null 57 (52.3%) 72 (50.4%)
 Missing 1 (0.9%) 0
GSTT1 (Gene deletion)
 Null 19 (17.4%) 21 (14.7%) NS
 Non-null 89 (81.7%) 122 (85.3%)
 Missing 1 (0.9%) 0

aP-value was based on those participants without missing data.